Financial Times’ US Pharma Biotech Summit 2022: Track & Invest in American Life Sciences
Karen Snow, Senior VP, Nasdaq's Head of US Listings and Revenue, noted that the stock market has been bullish for a decade and in the face of current financial strains, due to COVID-related inflation and supply chain issues, it is now time for course-correction.